Interleukin-1 Receptor-Associated Kinase-3 Is a Key Inhibitor of Inflammation in Obesity and Metabolic Syndrome

PLoS ONE - United States
doi 10.1371/journal.pone.0030414
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Conformational Flexibility and Inhibitor Binding to Unphosphorylated Interleukin-1 Receptor–associated Kinase 4 (IRAK4)

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Immunodeficiency Due to Interleukin-1 Receptor-Associated Kinase-4 Deficiency

2020English

Obesity and Metabolic Inflammation

Drug Discovery Today: Disease Mechanisms
2013English

Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2011English

Among Inflammation and Coagulation Markers, PAI-1 Is a True Component of the Metabolic Syndrome

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2006English

Interleukin-1, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist

Proceedings of the Nutrition Society
MedicineNutritionDietetics
1994English

Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Hookah Smoking Is Strongly Associated With Diabetes Mellitus, Metabolic Syndrome and Obesity: A Population-Based Study

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Toll-Like Interleukin 1 Receptor Regulator Is an Important Modulator of Inflammation Responsive Genes

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy